Research on Dong Quai specifically for blood circulation is very limited within the available evidence. The one study identified is a 2020 systematic scoping review that examined traditional Chinese medicine formulations — including those potentially containing Dong Quai as a component — primarily in the context of COVID-19 and inflammatory pathway modulation, rather than blood circulation as a standalone outcome. Studies indicate that this review was neutral in direction and focused on molecular mechanisms rather than providing clinical evidence for circulatory benefits. Given the indirect and narrowly scoped nature of the available research, meaningful conclusions about Dong Quai's effects on blood circulation cannot be drawn from this evidence base alone, and readers should be aware that the existing literature does not directly address this use.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Molecular Mechanism of Action of Repurposed Drugs and Traditional Chinese Med... | Other | 2020 | Neutral | 90 |